Stoking the drug target pipeline for human African trypanosomiasis

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Molecular Microbiology

• Publication date

  2012-10-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/mmi.12001PMID 22925123PMCID PMC3456963
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Antiparasitic agents: new drugs on the horizon.

  2012cited by this paper
• Back to the Future: Lessons Learned in Modern Target-based and Whole-Cell Lead Optimization of Antimalarials

  2012cited by this paper
• Chemical, genetic and structural assessment of pyridoxal kinase as a drug target in the African trypanosome

  2012cited by this paper
• Trypanosomal immune evasion, chronicity and transmission: an elegant balancing act

  2012cited by this paper
• The Anti-Trypanosome Drug Fexinidazole Shows Potential for Treating Visceral Leishmaniasis

  2012cited by this paper
• Diagnosis of human sleeping sickness: sense and sensitivity.

  2011cited by this paper
• Development of novel drugs for human African trypanosomiasis.

  2011cited by this paper
• High-throughput phenotyping using parallel sequencing of RNA interference targets in the African trypanosome.

  2011cited by this paper
• RNA Interference in Protozoan Parasites: Achievements and Challenges

  2011cited by this paper
• Antitrypanosomal Activity of Fexinidazole, a New Oral Nitroimidazole Drug Candidate for Treatment of Sleeping Sickness

  2011cited by this paper
• High-throughput decoding of anti-trypanosomal drug efficacy and resistance

  2011influential reference
• Drug discovery and development for neglected diseases: the DNDi model

  2011influential reference
• SCYX-7158, an Orally-Active Benzoxaborole for the Treatment of Stage 2 Human African Trypanosomiasis

  2011influential reference
• TDR Targets: a chemogenomics resource for neglected diseases

  2011cited by this paper
• Structure-guided lead optimization of triazolopyrimidine-ring substituents identifies potent Plasmodium falciparum dihydroorotate dehydrogenase inhibitors with clinical candidate potential.

  2011cited by this paper
• Gene expression in Trypanosoma brucei: lessons from high-throughput RNA sequencing.

  2011cited by this paper
• The Trypanocidal Drug Suramin and Other Trypan Blue Mimetics Are Inhibitors of Pyruvate Kinases and Bind to the Adenosine Site*

  2011influential reference
• Nifurtimox Activation by Trypanosomal Type I Nitroreductases Generates Cytotoxic Nitrile Metabolites

  2011influential reference
• State of the art in African trypanosome drug discovery.

  2011cited by this paper
• Challenges in antimalarial drug discovery.

  2011cited by this paper
• The state of the art in anti-malarial drug discovery and development.

  2011cited by this paper
• NECT Is Next: Implementing the New Drug Combination Therapy for Trypanosoma brucei gambiense Sleeping Sickness

  2010cited by this paper
• Chemotherapy against human African trypanosomiasis: Is there a road to success?

  2010cited by this paper
• Potential new drugs for human African trypanosomiasis: some progress at last

  2010cited by this paper
• Plasmodium dihydroorotate dehydrogenase: a promising target for novel anti-malarial chemotherapy.

  2010cited by this paper
• Human African trypanosomiasis

  2010cited by this paper
• A mechanism for cross-resistance to nifurtimox and benznidazole in trypanosomes

  2008influential reference
• The continuing problem of human African trypanosomiasis (sleeping sickness)

  2008influential reference
• Kinetoplastids: related protozoan pathogens, different diseases.

  2008influential reference
• Genomic-scale prioritization of drug targets: the TDR Targets database

  2008cited by this paper
• Human African trypanosomiasis: pharmacological re‐engagement with a neglected disease

  2007cited by this paper
• The Mitochondrion Is a Site of Trypanocidal Action of the Aromatic Diamidine DB75 in Bloodstream Forms of Trypanosoma brucei

  2007influential reference
• The Genome of the African Trypanosome Trypanosoma brucei

  2005cited by this paper
• The Genome of the African Trypanosome

  2002cited by this paper
• Trypanosoma brucei

  1998cited by this paper

• Current Prospects of Saponins as Promising Anti-Trypanosoma Brucei Compounds: Insight into the Mechanisms of Action.

  2023cites this paper
• Molecular scaffold recognition of drug molecules against essential genes of Leishmania donovani using biocomputing approach

  2023cites this paper
• Dihydroorotate dehydrogenase inhibitors in anti-infective drug research.

  2019cites this paper
• Pyridoxal kinase: A vitamin B6 salvage pathway enzyme from Leishmania donovani.

  2018cites this paper
• Potential Drug Targets in the Pentose Phosphate Pathway of Trypanosomatids.

  2017cites this paper
• New Models of Drug Discovery and Development for Neglected Disease Populations

  2017cites this paper
• Drugs for Treating Protozoan Infections

  2016cites this paper
• The Oral Antimalarial Drug Tafenoquine Shows Activity against Trypanosoma brucei

  2015cites this paper
• Expression and crystallization of the plant alternative oxidase.

  2015cites this paper
• Facile Synthesis and Preliminary Structure-Activity Analysis of New Sulfonamides Against Trypanosoma brucei.

  2014cites this paper
• Synthesis and antiprotozoal activity of oligomethylene- and p-phenylene-bis(methylene)-linked bis(+)-huprines.

  2014cites this paper
• The medicinal chemistry development for new antimicrobial chemotherapeutics

  2014cites this paper
• Recent approaches to chemical discovery and development against malaria and the neglected tropical diseases human African trypanosomiasis and schistosomiasis.

  2014cites this paper
• In Vitro Imaging of Trypanosoma cruzi Host Infection Systems for Evaluation of Compound Activity

  2014cites this paper
• DOCLASP - Docking ligands to target proteins using spatial and electrostatic congruence extracted from a known holoenzyme and applying simple geometrical transformations

  2014cites this paper
• Trypanosoma brucei S-Adenosylmethionine Decarboxylase N Terminus Is Essential for Allosteric Activation by the Regulatory Subunit Prozyme*

  2013cites this paper
• Structure of the trypanosome cyanide-insensitive alternative oxidase

  2013cites this paper
• Approaches to protozoan drug discovery: phenotypic screening.

  2013cites this paper
• Determination of antiprotozoal drug mechanisms by metabolomics approaches

  2013cites this paper